SO-34: Impact of BRAF-V600E mutation on immunologic characteristics of the tumor microenvironment (TME) and associated genomic alterations in patients with microsatellite instability-high (MSI-H) or mismatch-repair–deficient (dMMR) colorectal cancer (CRC) - Mohamed Salem, et al
SO-35: T-cell abundance measured by immunoSEQ predicts overall survival in colorectal cancer - Stephen Gruber, et al
SO-36: An immune-related gene expression profile predicts the efficacy of adding atezolizumab to first-line FOLFOXIRI/bevacizumab in metastatic colorectal cancer: a translational analysis of the phase II randomized AtezoTRIBE study - Carlotta Antoniotti, et al
